---
title: "Artemisinin - Falciparum Malaria"
sidebar: mydoc_sidebar
permalink: db13132-mesh-d016778-1.html
toc: false 
---


Path ID: `DB13132_MESH_D016778_1`
{% include image.html url="images/db13132-mesh-d016778-1.png" file="db13132-mesh-d016778-1.png" alt="db13132-mesh-d016778-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C031327 | artemisinin | Drug |
| CHEBI:207229 | dihydroartemisinin | ChemicalSubstance |
| UniProt:Q8I3Z5 | Translationally controlled tumor protein (TCTP) homolog | Protein |
| NCBITaxon:5833 | Plasmodium falciparum | OrganismTaxon |
| MESH:D016778 | Falciparum malaria | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Artemisinin | HAS METABOLITE | Dihydroartemisinin |
| Dihydroartemisinin | DECREASES ACTIVITY OF | Translationally Controlled Tumor Protein (Tctp) Homolog |
| Translationally Controlled Tumor Protein (Tctp) Homolog | PART OF | Plasmodium Falciparum |
| Plasmodium Falciparum | CAUSES | Falciparum Malaria |
|---------|-----------|---------|

Comment: The exact mechanism of artemisinin action is not completely understood, It was proposed to generate free-radicals due to its unique structure endoperoxide bridge. The MoA proposed here is the one of the drug target identified for artemisinin mode of action with solid experimental evidence.

Reference: 
  - [https://go.drugbank.com/drugs/DB13132](https://go.drugbank.com/drugs/DB13132)
  - [https://link.springer.com/article/10.1007%2Fs00709-015-0805-6](https://link.springer.com/article/10.1007%2Fs00709-015-0805-6)
  - [https://en.wikipedia.org/wiki/Artemisinin](https://en.wikipedia.org/wiki/Artemisinin)
